Clean Science and Technology Subscribes to Shares in Wholly Owned Subsidiary, Clean Fino-Chem Limited
Clean Science and Technology Limited (CSTL) has subscribed to an additional 8,36,121 Equity Shares of its wholly owned subsidiary, Clean Fino-Chem Limited (CFCL). The investment was made via a subscription to the Rights Issue of CFCL, involving a total cash consideration of Rs. 50,00,00,358/-.The subscription involved issuing shares with a face value of Rs. 10/- each and at a premium of Rs. 588/- per share. These newly issued equity shares will rank pari passu with the existing equity shares of Clean Fino-Chem Limited.
CFCL, which operates in the Speciality Chemicals industry, was incorporated on March 22, 2022, as a wholly owned subsidiary of CSTL and is based in India. The acquisition of additional capital is intended primarily for funding the company's projects. The transaction has been noted as being at arm’s length, although CFCL remains a related party to CSTL.
The financial profile of Clean Fino-Chem Limited shows continuous growth across its last three financial years:
| Financial Metric | 31st March 2024 | 31st March 2025 | 31st March 2026 |
|---|---|---|---|
| Turnover | Rs. 1.92 Crore | Rs. 46.77 Crore | Rs. 166 Crore |
Key details of the share subscription and the target entity are summarized below:
| Particulars | Details |
|---|---|
| Target Entity | Clean Fino-Chem Limited (Wholly Owned Subsidiary) |
| Shares Subscribed | 8,36,121 Equity Shares |
| Face Value per Share | Rs. 10/- |
| Premium Paid | Rs. 588/-(Rupees Five Hundred and Eighty-Eight Only) |
| Total Subscription Amount | Rs. 50,00,00,358/- (Rupees Fifty Crores Three Hundred and Fifty-Eight Only) |
| Industry | Speciality Chemicals |
| Nature of Transaction | 100% subscription to the equity share capital in cash |
CLEAN Stock Price Movement
Clean Science and Technology Limited shares today slipped by 1.71% to settle at ₹788.6 after trading in the equity segment. The stock saw a total traded volume of 258,602 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.